Supreme Court Ponders U.S. Reach In Vitamin Antitrust Case Oral Arguments
This article was originally published in The Tan Sheet
Executive Summary
Allowing antitrust claims in U.S. courts for injuries sustained in foreign commerce will weaken amnesty programs designed to detect international cartels, the government argued before the Supreme Court April 26 in a longstanding vitamin antitrust price-fixing case